Inovio Pharma (INO) Stock Price, Quote & News

Company Profile

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline inclu...

Industry: Biotechnology

Sector: Healthcare

Phone: 267 440 4200

Website: www.inovio.com

Address:

660 West Germantown Pike, Suite 110, Plymouth Meeting, United States

Dany_italy Dec. 25 at 2:29 PM

$INO As an Italian with strong ties to tradition, I cannot fail to wish you and your families, wherever you may be in the world, a peaceful Christmas from myself and my family. If it is meant to be, we will win this long battle too. Peace to you all. Buon Natale amici miei!

1 · Reply

Lookingdown Dec. 25 at 10:00 AM

$INO "May your Christmas sparkle and your New Year shine" Merry Christmas Everyone 🤶 🎄

3 · Reply

NoodleNetWorth Dec. 25 at 9:31 AM

$INO Strategic positioning matters less than consistent throughput, amid evolving funding conditions and shifting competitive responses. Clear follow‑through could unlock sustainable re‑rating.

0 · Reply

1iquid Dec. 25 at 12:56 AM

💎 Liquid® Live Actionable Trade Asset: $INO Contracts: $INO December 18, 2026 $3 Calls Scale in: $0.51- $0.62 Scale out: $1.97-$3.38 Profit Potential : 393% ROI Blended Join 💎 Here: https://1iquid.com

0 · Reply

RajCx Dec. 24 at 10:18 PM

$INO Short interest as of 12/15 further up. Not sure what’s going on. Trapping retails shorts or hedge funds shorting more??

1 · Reply

Tracker7 Dec. 24 at 10:12 PM

$INO Merry Christmas bulls! Bashers, you’ve been bad, so no presents for you! You only get a lump of coal.

1 · Reply

updownsides Dec. 24 at 10:04 PM

$INO when you use PT from Piper and Oppenheimer, who did the last 4 offerings going backnto 2024, of course you get a bloated PT. How about Jeffries $1.80 PT lowered from $2.00 . Now that's a believable PT. Remember, INO only has enough cash runway into the first half of 2026. This means more dilution in the next few months. The warrants overhang and the dilution will bring another price dive without any bad news in itself.

0 · Reply

INOVIO Dec. 24 at 9:51 PM

$INO Nice short interest jumped almost 1mil! Sitting now 9.45mil! Shorts are just digging themselves deeper and deeper, it will be a nice short squeeze when BLA acceptance news is released!!

2 · Reply

Lookingdown Dec. 24 at 9:41 PM

$INO Yep looks good to me 😉💪💎

0 · Reply

Inoboatguy Dec. 24 at 6:52 PM

$INO blocked 🚫 all 50 of your accounts lol still very

0 · Reply

INOVIO Reports Inducement Grant Under Inducement Plan

Dec 2, 2025, 10:13 AM EST - 23 days ago

Inovio Pharmaceuticals, Inc. (INO) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Nov 18, 2025, 8:05 AM EST - 5 weeks ago

INOVIO to Participate in December Investor Conferences

Nov 12, 2025, 9:53 AM EST - 6 weeks ago

Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress

Nov 11, 2025, 8:40 AM EST - 6 weeks ago

INOVIO Announces Pricing of $25 Million Public Offering

Nov 10, 2025, 7:31 PM EST - 6 weeks ago

Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 6:09 PM EST - 6 weeks ago

INOVIO Announces Proposed Public Offering

Nov 10, 2025, 4:05 PM EST - 6 weeks ago

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Nov 3, 2025, 8:05 AM EST - 7 weeks ago

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Oct 27, 2025, 8:05 AM EDT - 2 months ago

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 23, 2025, 4:05 PM EDT - 2 months ago

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Oct 21, 2025, 8:05 AM EDT - 2 months ago

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Sep 25, 2025, 8:05 AM EDT - 3 months ago

INOVIO to Participate in Upcoming Scientific Conferences

Sep 5, 2025, 9:37 AM EDT - 3 months ago

Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)

Aug 26, 2025, 8:05 AM EDT - 4 months ago

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

Aug 25, 2025, 8:05 AM EDT - 4 months ago

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 13, 2025, 3:26 AM EDT - 4 months ago

Inovio Pharmaceuticals, Inc. (INO) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 4 months ago

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Aug 11, 2025, 8:05 AM EDT - 4 months ago

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Aug 4, 2025, 4:05 PM EDT - 5 months ago

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 7, 2025, 4:05 PM EDT - 6 months ago

INOVIO to Present at Upcoming Scientific Conference

Jul 1, 2025, 7:00 AM EDT - 6 months ago

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

May 13, 2025, 7:05 PM EDT - 8 months ago

Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 8 months ago

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 9, 2025, 7:37 PM EDT - 8 months ago

Inovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript)

Apr 30, 2025, 8:05 AM EDT - 8 months ago

INOVIO to Present at Upcoming Scientific and Investor Conferences

Apr 29, 2025, 8:05 AM EDT - 8 months ago

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 9, 2025, 8:05 AM EDT - 9 months ago

INOVIO to Present at Upcoming Scientific Conferences

Mar 18, 2025, 8:48 PM EDT - 10 months ago

Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:05 PM EDT - 10 months ago

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 13, 2025, 6:15 PM EDT - 10 months ago

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

Mar 12, 2025, 12:55 PM EDT - 10 months ago

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Feb 12, 2025, 5:39 PM EST - 11 months ago

Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript)

Feb 12, 2025, 8:00 AM EST - 11 months ago

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

Feb 10, 2025, 8:05 AM EST - 11 months ago

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

Jan 29, 2025, 4:14 PM EST - 11 months ago

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 9, 2025, 8:04 AM EST - 1 year ago

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

Jan 6, 2025, 7:19 AM EST - 1 year ago

Top 3 Health Care Stocks That Could Blast Off This Month

OTLK RCKT

Dec 13, 2024, 2:10 PM EST - 1 year ago

Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet

Dec 13, 2024, 7:00 AM EST - 1 year ago

INOVIO Announces Pricing of $30 Million Public Offering

Dec 3, 2024, 8:00 AM EST - 1 year ago

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

Nov 15, 2024, 11:21 AM EST - 1 year ago

European And US Vaccine Stocks Are Under Pressure - Here's WHy

AZN BNTX GSK MRK SNY VALN

Nov 14, 2024, 7:53 PM EST - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:05 PM EST - 1 year ago

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 13, 2024, 8:00 AM EST - 1 year ago

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial

Nov 6, 2024, 8:00 AM EST - 1 year ago

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

Oct 21, 2024, 8:00 AM EDT - 1 year ago

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP

Oct 2, 2024, 4:15 PM EDT - 1 year ago

INOVIO Reports Inducement Grants Under Inducement Plan

Aug 9, 2024, 3:32 AM EDT - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 1 year ago

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Dany_italy Dec. 25 at 2:29 PM

1 · Reply

Lookingdown Dec. 25 at 10:00 AM

$INO "May your Christmas sparkle and your New Year shine" Merry Christmas Everyone 🤶 🎄

3 · Reply

NoodleNetWorth Dec. 25 at 9:31 AM

$INO Strategic positioning matters less than consistent throughput, amid evolving funding conditions and shifting competitive responses. Clear follow‑through could unlock sustainable re‑rating.

0 · Reply

1iquid Dec. 25 at 12:56 AM

0 · Reply

RajCx Dec. 24 at 10:18 PM

$INO Short interest as of 12/15 further up. Not sure what’s going on. Trapping retails shorts or hedge funds shorting more??

1 · Reply

Tracker7 Dec. 24 at 10:12 PM

$INO Merry Christmas bulls! Bashers, you’ve been bad, so no presents for you! You only get a lump of coal.

1 · Reply

updownsides Dec. 24 at 10:04 PM

0 · Reply

INOVIO Dec. 24 at 9:51 PM

$INO Nice short interest jumped almost 1mil! Sitting now 9.45mil! Shorts are just digging themselves deeper and deeper, it will be a nice short squeeze when BLA acceptance news is released!!

2 · Reply

Lookingdown Dec. 24 at 9:41 PM

$INO Yep looks good to me 😉💪💎

0 · Reply

Inoboatguy Dec. 24 at 6:52 PM

$INO blocked 🚫 all 50 of your accounts lol still very

0 · Reply

Inoboatguy Dec. 24 at 6:50 PM

$INO what's your first name? Why do you post using many accounts and repost the same garbage 🗑 nonsense.. You know nothing!

0 · Reply

updownsides Dec. 24 at 6:48 PM

$INO Does she want you to profit?

0 · Reply

INOVIO Dec. 24 at 6:08 PM

$INO Merry Christmas everyone! See you all on Friday! Go INOVIO!

0 · Reply

updownsides Dec. 24 at 6:01 PM

$INO You obviously haven't done your homework. Believe what you want. How did it feel minutes after earnings call yet another offering dilluted this turd. Know how warrants work? You'll find out soon enough.

1 · Reply

tau72 Dec. 24 at 6:00 PM

$INO We could see $22.8 on 12/24/2026...GLTA

0 · Reply

Inoboatguy Dec. 24 at 5:58 PM

$INO

0 · Reply

updownsides Dec. 24 at 5:56 PM

$INO $OMER $INO Can't compare this turd with OMER. They didn't have massive warrants capping the rise. Unfortunately for you guys, Ino has the worst management around. They diluted you so much and still have layers of warrants that need to be absorbed. Lucky if BLA is accepted and if so the first tranch of warrants block any sustained price increase. After that it's 110% getting a CRL thanks to Cellectra as well all the outsourced companies that can't have hair out of place.

1 · Reply

spotteddoggie Dec. 24 at 5:37 PM

$INO A few nickels came my way. I spent them on a few more shares. As for when the PR drops, I expect it will come the first full week of January. Gotta give the hedgies a chance to quietly buy and get out of their hole. Okay, let them. As long as the SP matches the real potential of Inovio. May the new year bring hope to a lot of patients hoping for and needing help. Inovio can bring it.

1 · Reply

tau72 Dec. 24 at 4:11 PM

$INO May announce BLA acceptance news on Friday PM or AH. Have a wonderful Merry Christmas to All.

1 · Reply

HARM20 Dec. 24 at 3:53 PM

$INO $OMER check out INOVIO, FDA BLA acceptance any any, any minute, any second! Huge upside potential! 💎 💎 $INO

0 · Reply

HARM20 Dec. 24 at 3:22 PM

$INO Just look at what $OMER when they got their approval. We are next in line. BLA acceptance any day now and then boom! $INO

1 · Reply

INOVIO Dec. 24 at 3:10 PM

$INO I can smell the BLA acceptance letter arriving in INOVIO’s headquarters!

0 · Reply

Market Cap	143.47M
Revenue (ttm)	220,000.00
Net Income (ttm)	-107.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-48,750.00%
Debt to Equity Ratio	0.00

Volume	712,200
Avg Vol	1,350,398
Day's Range	N/A - N/A
Shares Out	66.73M
Stochastic %K	32%
Beta	1.54
Analysts	Strong Sell
Price Target	$7.63